Real time MRI-TRUS fusion image-guided transperineal target biopsy for the detection of the significant prostate cancer with BioJet system

Real time MRI-TRUS fusion image-guided transperineal target biopsy for the detection of the significant prostate cancer with BioJet system - MRI-TRUS fusion image-guided biopsy for detection of the significant prostate cancer with BioJet system

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023240

Enrollment

400

Registered

2016-07-20

Start date

2013-12-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cacer

Interventions

Target biopsies for each cancer-suspicious lesion and 12 systematic biopsies would be performed using the BioJet system. Pathological findings of targeted and systematic biopsies were analyzed.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. The patients with PSA level greater than 4.0 ng/ml and less than 20 ng/ml were performed mpMRI prospectively. 2. Consecutive patients with suspected prostate cancer from multiparametric MRI were recruited prospectively.

Exclusion criteria

Exclusion criteria: The patients with PSA level greater than 20ng/ml.

Design outcomes

Primary

Measure	Time frame
Target biopsies for each cancer-suspicious lesion and 12 systematic biopsies would be performed using the BioJet system. Pathological findings of targeted and systematic biopsies were analyzed.	—

Countries

Japan

Contacts

Public ContactSunao Shoji

Tokai Univeristy Hachioji Hospital Department of Urology

sunashoj@mail.goo.ne.jp042-639-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026